Literature DB >> 15701641

Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif.

Archana Jalota1, Kamini Singh, Lakshminarasimhan Pavithra, Ruchika Kaul-Ghanekar, Shahid Jameel, Samit Chattopadhyay.   

Abstract

Various stresses and DNA-damaging agents trigger transcriptional activity of p53 by post-translational modifications, making it a global regulatory switch that controls cell proliferation and apoptosis. Earlier we have shown that the novel MAR-associated protein SMAR1 interacts with p53. Here we delineate the minimal domain of SMAR1 (the arginine-serine-rich domain) that is phosphorylated by protein kinase C family proteins and is responsible for p53 interaction, activation, and stabilization within the nucleus. SMAR1-mediated stabilization of p53 is brought about by inhibiting Mdm2-mediated degradation of p53. We also demonstrate that this arginine-serine (RS)-rich domain triggers the various cell cycle modulating proteins that decide cell fate. Furthermore, phenotypic knock-down experiments using small interfering RNA showed that SMAR1 is required for activation and nuclear retention of p53. The level of phosphorylated p53 was significantly increased in the thymus of SMAR1 transgenic mice, showing in vivo significance of SMAR1 expression. This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the "guardian of the genome."

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701641     DOI: 10.1074/jbc.M413200200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

2.  Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.

Authors:  Surajit Sinha; Sunil Kumar Malonia; Smriti P K Mittal; Kamini Singh; Sreenath Kadreppa; Rohan Kamat; Robin Mukhopadhyaya; Jayanta K Pal; Samit Chattopadhyay
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

3.  Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.

Authors:  Shravanti Rampalli; L Pavithra; Altaf Bhatt; Tapas K Kundu; Samit Chattopadhyay
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

4.  Conserved Ser/Arg-rich motif in PPZ orthologs from fungi is important for its role in cation tolerance.

Authors:  Anupriya Minhas; Anupam Sharma; Harsimran Kaur; Yashpal Rawal; Kaliannan Ganesan; Alok K Mondal
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

5.  Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway.

Authors:  Wenjing Luo; Jinyi Liu; Jingxia Li; Dongyun Zhang; Mingchao Liu; James K Addo; Shivaputra Patil; Lin Zhang; Jian Yu; John K Buolamwini; Jingyuan Chen; Chuanshu Huang
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

6.  Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment.

Authors:  Sandeep Singh; Varsheish Raina; Pavithra Lakshminarsimhan Chavali; Taronish Dubash; Sreenath Kadreppa; Pradeep Parab; Samit Chattopadhyay
Journal:  BMC Mol Biol       Date:  2012-09-14       Impact factor: 2.946

7.  Tumor suppressor protein SMAR1 modulates the roughness of cell surface: combined AFM and SEM study.

Authors:  Ruchika Kaul-Ghanekar; Sandeep Singh; Hitesh Mamgain; Archana Jalota-Badhwar; Kishore M Paknikar; Samit Chattopadhyay
Journal:  BMC Cancer       Date:  2009-10-02       Impact factor: 4.430

8.  Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

Authors:  Gannie Tzoneva; Arianne Perez-Garcia; Zachary Carpenter; Hossein Khiabanian; Valeria Tosello; Maddalena Allegretta; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Jana Hof; Renate Kirschner-Schwabe; Teresa Palomero; Raul Rabadan; Adolfo Ferrando
Journal:  Nat Med       Date:  2013-02-03       Impact factor: 53.440

9.  p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.

Authors:  Kamini Singh; Devraj Mogare; Ramprasad Obula Giridharagopalan; Rajinikanth Gogiraju; Gopal Pande; Samit Chattopadhyay
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

10.  Stabilization of SMAR1 mRNA by PGA2 involves a stem loop structure in the 5' UTR.

Authors:  Lakshminarasimhan Pavithra; Shravanti Rampalli; Surajit Sinha; Kadreppa Sreenath; Richard G Pestell; Samit Chattopadhyay
Journal:  Nucleic Acids Res       Date:  2007-08-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.